Benign Prostatic Hyperplasia Treatment Market to Reach USD 47 Billion by 2034, Driven by 3.6% CAGR Amidst Aging Population and Minimally Invasive Innovations
The global Benign Prostatic Hyperplasia (BPH) Prostate Treatment Market is projected for substantial growth, with